What sector does GeneBioTechCo.,Ltd. belong to?

GeneBioTechCo.,Ltd. operates in the Consumer Discretionary sector, specifically the Consumer Discretionary industry, and is listed on the US markets.

What is the current share price of 086060?

As of the latest available quote, 086060 traded at ₩4,825.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 086060?

GeneBioTechCo.,Ltd. has a price-to-earnings (P/E) ratio of about 10.97. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 086060?

The market capitalisation of GeneBioTechCo.,Ltd. is approximately ₩41.55B.

Is GeneBioTechCo.,Ltd. profitable?

For its latest reported financial year, GeneBioTechCo.,Ltd. recorded a net profit margin of about 4.17%.

Does 086060 pay a dividend?

GeneBioTechCo.,Ltd. currently has a dividend yield of about 1.25%.

What is the return on equity (ROE) of 086060?

GeneBioTechCo.,Ltd. has a return on equity (ROE) of about 6.89%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 086060?

Over the past 52 weeks, 086060 has traded between a low of ₩3,525.00 and a high of ₩5,990.00.

GeneBioTechCo.,Ltd.

086060 KRX Consumer Discretionary Consumer Discretionary

KOSDAQ

₩4,825.00

+0.00%

Delayed · cached 15 min

Fair value analysis

086060

GeneBioTechCo.,Ltd.

₩4,825.00

Close used for this calculation

₩6,861.36Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

54/100

Profitability4/25

Returns8/25

Balance Sheet21/25

Efficiency21/25

Growth11/25

Good

Quality radar

Consensus fair value

₩6,861.36

Below FV

▲ +42.2% against the close used

Model range ₩768.98 – ₩8,800.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩768.98Fair value₩6,861.36Bull₩8,800.00

FairClose

52-week traded range

52W low ₩4,600.0052W high ₩5,160.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

GeneBioTechCo.,Ltd. closed at ₩4,825.00, 29.7% below the consensus fair value of ₩6,861.36 drawn from 8 valuation models.

Financial DNA score 54/100 — Good. P/E of 11.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩8,393.90

+74.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩7,927.92

+64.3%

√(22.5 × EPS × BVPS)

EPS=440, BVPS=6348.68

P/E Fair Value

₩8,800.00

+82.4%

EPS × 20x (sector P/E)

EPS=440, Sector P/E=20x

EV/EBITDA

₩2,834.26

-41.3%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=3.92B

Dividend Discount (DDM)

₩768.98

-84.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=60.31, r=10%, g=2%

Book Value (P/B)

₩3,528.05

-26.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=6348.68, ROE=6.9%, g=3%, r=10%

Reverse DCF

₩4,825.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -1% | Historical: 0%

Margin of Safety

₩6,280.46

+30.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=8373.94, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer